http://www.oryzon.com/rss Oryzon Genomics http://www.oryzon.com Noticias de oryzon.com es info@oryzon.com info@oryzon.com Oryzon to Present its LSD1 program in Acute Leukemias at the GTC’s 2nd Epigenetics in Drug Discovery conference in Bostonhttp://www.oryzon.com/en/news/oryzon-to-present-its-lsd1-program-in-acute-leukemias-at-the-gtc-s-2nd-epigenetics-in-drug-discovery-conference-in-boston/141Drugs from ORYZON shown to be efficacious in the treatment of Acute Leukemiahttp://www.oryzon.com/en/news/drugs-from-oryzon-shown-to-be-efficacious-in-the-treatment-of-acute-leukemia/139Oryzon to attend BIO-Europe Spring 2012 Conference in Amsterdamhttp://www.oryzon.com/en/news/oryzon-to-attend-bio-europe-spring-2012-conference-in-amsterdam/136Oryzon participates in a R&D European consortium in Parkinson’s diseasehttp://www.oryzon.com/en/news/oryzon-participates-in-a-r-amp-d-european-consortium-in-parkinson-s-disease/135Oryzon nominates bispecific LSD1/MAOB inhibitor as drug candidate to enter preclinical development in Huntington´s Diseasehttp://www.oryzon.com/en/news/oryzon-nominates-bispecific-lsd1-maob-inhibitor-as-drug-candidate-to-enter-preclinical-development-in-huntington-s-disease/133Oryzon to Present at 4th CHI X-Gen Congress, Epigenetics, Targets and Therapies on March 6http://www.oryzon.com/en/news/oryzon-to-present-at-4th-chi-x-gen-congress-epigenetics-targets-and-therapies-on-march-6/131Oryzon will launch its first product onto the markethttp://www.oryzon.com/en/news/oryzon-will-launch-its-first-product-onto-the-market/129Oryzon on the official program of the Euromediag International Convention (EIC 2011)http://www.oryzon.com/en/news/oryzon-on-the-official-program-of-the-euromediag-international-convention-eic-2011-/104Dr. Marta Palicio, Scientific Business Developer at Oryzon, has been invited to participate in the roundtable Biomarkers and translational medicine: new paradigms for personalized medicinehttp://www.oryzon.com/en/news/dr-marta-palicio-scientific-business-developer-at-oryzon-has-been-invited-to-participate-in-the-roundtable-biomarkers-and-translational-medicine-new-paradigms-for-personalized-medicine/105Oryzon is present at the Bio International Convention of USAhttp://www.oryzon.com/en/news/oryzon-is-present-at-the-bio-international-convention-of-usa/108Oryzon is present in the 76th Spanish National Congress of Urologyhttp://www.oryzon.com/en/news/oryzon-is-present-in-the-76th-spanish-national-congress-of-urology/106Oryzon presents the results of the clinical study of GynEC-Dx: detection of endometrial cancer producthttp://www.oryzon.com/en/news/oryzon-presents-the-results-of-the-clinical-study-of-gynec-dx-detection-of-endometrial-cancer-product/111Oryzon to Present at BioTrinity 2011 Conference in UKhttp://www.oryzon.com/en/news/oryzon-to-present-at-biotrinity-2011-conference-in-uk/112Oryzon to Present Recent Advances from its Project 'Innovative Approaches and Biomarkers in Parkinson Disease' at a Symposium in Barcelonahttp://www.oryzon.com/en/news/oryzon-to-present-recent-advances-from-its-project-innovative-approaches-and-biomarkers-in-parkinson-disease-at-a-symposium-in-barcelona/114Oryzon Licenses Human Antibody Phage Display Technology for Discovery of Novel Therapeuticshttp://www.oryzon.com/en/news/oryzon-licenses-human-antibody-phage-display-technology-for-discovery-of-novel-therapeutics/99Oryzon to Participate at the SMR Epigenetics symposium in London, UK.http://www.oryzon.com/en/news/oryzon-to-participate-at-the-smr-epigenetics-symposium-in-london-uk-/118